Greenphire, a provider of payment technology for the clinical trials industry, has won a place in Deloitte's 2014 Technology Fast 500. Ranking 48th in the annual list of the fastest growing technology companies in the U.S, Greenphire secured its place as a result of an exceptional 2782% growth over the past four years.

Deloitte's Fast 500 ranking is based on percentage of fiscal year revenue growth from 2009-2013. Greenphire credits its incredible growth to the clinical trials industry's resolute demand for its global payment technologies that transform the clinical payment management process. The solutions empower customers to enhance the financial health of their clinical trials, replacing burdensome manual tasks with platform-driven tools that help improve operational efficiency, reduce costs, bring transparency to financial transactions and increase subject retention and compliance.

Sam Whitaker, CEO, Greenphire, said, "Because Deloitte measures sustained revenue growth over four years, being included is a very impressive achievement that our exceptional team has worked determinedly together to accomplish. Our growth has been fuelled by the industry's increasing recognition that effective payment processes can contribute significantly to the success of a trial and we are all immensely looking forward to seeing what we can continue to achieve over the next four years."